Keybank National Association OH Buys Shares of 15,766 Pediatrix Medical Group, Inc. $MD

Keybank National Association OH purchased a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 15,766 shares of the company’s stock, valued at approximately $226,000.

Several other large investors also recently added to or reduced their stakes in the company. Freedom Investment Management Inc. purchased a new stake in Pediatrix Medical Group during the second quarter valued at about $151,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Pediatrix Medical Group in the second quarter valued at approximately $1,033,000. Nordea Investment Management AB lifted its stake in shares of Pediatrix Medical Group by 1.6% during the 2nd quarter. Nordea Investment Management AB now owns 268,219 shares of the company’s stock valued at $3,793,000 after buying an additional 4,159 shares in the last quarter. Allianz Asset Management GmbH lifted its stake in shares of Pediatrix Medical Group by 159.1% during the 2nd quarter. Allianz Asset Management GmbH now owns 61,412 shares of the company’s stock valued at $881,000 after buying an additional 37,712 shares in the last quarter. Finally, Inspire Investing LLC bought a new position in Pediatrix Medical Group in the 2nd quarter worth approximately $920,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Leerink Partners increased their target price on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a research report on Friday, September 5th. Wall Street Zen upgraded Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 4th. Truist Financial set a $17.00 price objective on Pediatrix Medical Group in a report on Tuesday, October 14th. UBS Group lifted their target price on Pediatrix Medical Group from $16.50 to $23.00 and gave the company a “neutral” rating in a report on Wednesday. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Pediatrix Medical Group in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, Pediatrix Medical Group currently has an average rating of “Hold” and a consensus price target of $18.40.

Pediatrix Medical Group Price Performance

NYSE:MD opened at $21.80 on Friday. Pediatrix Medical Group, Inc. has a 52-week low of $11.84 and a 52-week high of $22.38. The stock has a fifty day moving average of $17.19 and a 200 day moving average of $15.05. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. The firm has a market capitalization of $1.90 billion, a price-to-earnings ratio of 16.90 and a beta of 1.20.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Monday, November 3rd. The company reported $0.67 earnings per share for the quarter, topping analysts’ consensus estimates of $0.46 by $0.21. The business had revenue of $492.88 million for the quarter, compared to analyst estimates of $476.45 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The company’s quarterly revenue was down 3.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.44 EPS. On average, research analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.